Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Computational Pathology, AI & Precision Diagnostics

PART OF Biomarkers, CDx & Precision Medicine US

23 - 24 September 2026 | Gaylord Pacific Resort & Convention Center, San Diego, CA

Programme Summary

The Computational Pathology, AI & Precision Diagnostics programme takes the precision medicine decision chain through to deployment: foundation models for biomarker discovery, AI in pathology workflows, computational biomarker analysis, AI-enabled stratification, and the regulatory journey for AI/ML-based CDx. The new personalized healthcare track then frames this around the patient themselves.

At the heart of the programme is the Day 2 track keynote from AstraZeneca on scaling computational pathology for the next generation of cancer therapies, supported by three dedicated tracks across the two days.

The wider event sits around it: the cross-programme regulatory panel on AI-derived biomarkers and CDx, the integrated diagnostics panel and direct connection points to the biomarker and multi-omics work throughout.

Computational Pathology Top Image

Day 2 Track Keynote

MARK GUSTAVSON, AstraZeneca

Mark Gustavson leads computational pathology work inside AstraZeneca's oncology R&D, focused on scaling AI-driven pathology platforms across the company's late-stage cancer therapy programmes. His session covers how computational pathology moves from proof-of-concept to a routine part of biomarker-driven drug development, and what scaling means in practice for AI/ML model validation, deployment and regulatory positioning.

Mark Gustavson Headshot

Computational Pathology Hackathon

The Computational Pathology Diagnostic Solution Hackathon will bring together clinicians, pathologists, AI experts, pharma biomarker teams, diagnostics partners, and regulatory stakeholders to develop practical computational pathology diagnostic solutions for real-world biomarker and clinical decision-making challenges. Focusing on 5 key questions, teams will have the chance to collaborate and discuss these challenges before providing a 10 minute presentation, with winners announced by our judges on the day.

Hackathon

2026 Highlights

The track keynote from Mark Gustavson of AstraZeneca anchors the programme, on scaling computational pathology for the next generation of cancer therapies.

Lauri Diehl (Gilead) covers foundation models for biomarker discovery whilst Wei-Ju Tseng (GSK) covers advancing precision medicine with AI-integrated histopathology imaging.

Plus sessions on computational biomarker analysis, AI/ML model validation pathways, and AI in pathology workflows. The Day 1 cross-programme regulatory panel covers what Merck, AstraZeneca's senior regulatory voices expect from AI-derived biomarkers and computational pathology CDx in 2026.

The new Precision Biomarkers & Personalized Healthcare track frames how advancements in pathology are benefiting the patient with Razik Yousfi (Tempus), Evita Sadimin (City of Hope) and Ahmed Fadiel (Chicago) looking at reliable AI, translating  AI and bridging workflows for Precision Medicine.

NextGen Biomed - What to Expect Networking 4
Our Community and Culture Circle Image
600

leading pharma, biotech, regulatory & academic delegates

700
pre-arranged 1-2-1 meetings, facilitating business growth
50
hours of presentations, discussions & interactive content
12
hours of networking breaks, including fireside chats & refreshments

See last year's highlights

Computational Pathology, AI & Precision Diagnostics Agenda at a Glance

DAY ONE

Track 6: Computational Pathology, Image Analysis & AI
Track 7: Precision Biomarkers & Personalized Healthcare

DAY TWO

Track 5: Utilizing Computational Pathology in Pharma Research & Commercialization
Track 6: Computational Pathology Diagnostics Hackathon  

BIOMEU On Page Agenda

Key Event Highlights

An unmissable journey awaits you: from celebrated keynote speakers and insightful private roundtables, to an exclusive gala dinner. Discover the moments that will transform your NextGen Omics & Spatial experience. 

Featured Speakers for Computational Pathology, AI & Precision Diagnostics US 2026

Ahmed Fadiel
Director, Computational Oncology Unit,
Institute for Genomics and Systems Biology, University of Chicago Medicine
Changhong Song
Team Leader, OCEA: Office of Clinical Evidence and Analysis,
FDA
Cheng Cui
Senior Translational Regulatory Affairs Director,
AstraZeneca
Evita Sadimin
Associate Professor, Pathology Informatics and Urological Pathology; Division Chief, Pathology Informatics and Data Science,
City of Hope National Medical Center
Georgia Cresswell
Pathology Solutions Specialist,
Deciphex Inc DBA Diagnexia US
Guneet Walia
Senior Director, Data Science & Digital Health,
Janssen Pharmaceutical Companies of Johnson & Johnson
Gustavo Rohde
Professor of Biomedical Engineering and Electrical and Computer Engineering,
University of Virginia
Jeanne Shen
Associate Director of Pathology, Center for Artificial Intelligence in Medicine & Imaging,
Stanford University Medical Center
Jennifer Giltnane
Executive Director, Distinguished Scientist,
Merck
Jianyu Rao
Professor of Pathology and Epidemiology, Vice Chair, Diagnostic Technology Innovation,
University of California, Los Angeles
Karen McCullough
Vice President, Oncology Regulatory Strategy,
AstraZeneca
Kristopher Standish
Senior Director, Data Science, AI/Computer Vision,
Johnson & Johnson
Lauri Diehl
Executive Director Pathobiology,
Gilead Sciences
Mark Gustavson
Senior Director, Computational Pathology,
AstraZeneca
Merlinda-Loriane Sewavi
CEO,
Syntheia Labs
Razik Yousfi
SVP and GM of AI Products,
Tempus
Reena Philip
Executive Director, Regulatory Liaison, Companion Diagnostics / In Vitro Diagnostics,
Merck
Sandro José de Souza
Professor of Bioinformatics ,
Federal University of Rio Grande do Norte
Soma Ghosh
Division Director, DMGP, Office of In Vitro Diagnostics ,
FDA
Sripad Ram
Director Digital Pathology and Image Analysis Group,
Pfizer Inc
Sriram Sridhar
Senior Director Translational Research and Data Science,
Genmab
Stefan Hamann
Senior Principal Scientist,
Boehringer Ingelheim RCV GmbH & Co KG
Suzanne Coberly
Senior Director, Research Pathology,
Bristol Myers Squibb
Wei-Ju Tseng
Associate Director - Digital Histology,
GSK

Interested in Sponsoring Computational Pathology, AI & Precision Diagnostics?

Connect with 600+ senior pharma R&D leaders, computational pathologists, AI platform heads and digital pathology programme leads. 74% of delegates at the last edition were actively seeking new solutions.

Pre Med + LSX Combined Logo

Unlock the Latest News and Insights

Sign-up for our regular LifeScienceXchange newsletter to keep up to date with all things Precision Medicine, direct to your inbox.

Pre Med Newsletter Icon-1

Partner With Us

Position your AI, computational pathology or diagnostics platform in front of the senior pharma R&D leaders, computational pathologists and digital pathology programme heads shaping the regulatory and operational future of AI-driven diagnostics. Sponsorship options include presentation slots, exhibition space, branded sessions and pre-arranged 1:1 meetings. 

Register Now

Computational pathology and AI in diagnostics, from foundation models to regulatory pathway.
San Diego. 23 – 24 September 2026.


Decision 1

Sentence describing Decision 1

Decision 2

Sentence describing Decision 2